This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A potential strategy against clinical carbapenem-resistant Enterobacteriaceae: antimicrobial activity study of sweetener-decorated gold nanoparticles in vitro and in vivo
Journal of Nanobiotechnology Open Access 06 November 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Witkowski, M. et al. The artificial sweetener erythritol and cardiovascular event risk. Nat. Med. https://doi.org/10.1038/s41591-023-02223-9 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fernández-Ruiz, I. Artificial sweetener linked to higher CVD risk. Nat Rev Cardiol 20, 283 (2023). https://doi.org/10.1038/s41569-023-00855-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-023-00855-5
This article is cited by
-
A potential strategy against clinical carbapenem-resistant Enterobacteriaceae: antimicrobial activity study of sweetener-decorated gold nanoparticles in vitro and in vivo
Journal of Nanobiotechnology (2023)
-
The association of obesity-related dietary patterns and main food groups derived by reduced-rank regression with cardiovascular diseases incidence and all-cause mortality: findings from 116,711 adults
European Journal of Nutrition (2023)